Helsinn Advanced Synthesis

Helsinn Advanced Synthesis (HAS) is the manufacturing division of the Swiss-based Helsinn Group, operating as a specialized Contract Development and Manufacturing Organization (CDMO). Headquartered in Biasca, Switzerland, the company focuses on the development and GMP production of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and Highly Potent APIs (HPAPIs). HAS provides a full range of services from early-stage process development and scale-up to large-scale commercial manufacturing, with a particular expertise in handling cytotoxic and highly potent compounds. The facility is equipped with state-of-the-art containment technologies and has a strong track record of successful inspections by global regulatory authorities, including the FDA. As a key partner to the global pharmaceutical and biotech industries, HAS supports the production of complex small molecule therapies across various therapeutic areas.